Goatpox virus (G20-LKV) vaccine strain elicits a protective response in cattle against lumpy skin disease at challenge with lumpy skin disease virulent field strain in a comparative study.


Journal

Veterinary microbiology
ISSN: 1873-2542
Titre abrégé: Vet Microbiol
Pays: Netherlands
ID NLM: 7705469

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 10 01 2020
revised: 12 04 2020
accepted: 15 04 2020
entrez: 28 5 2020
pubmed: 28 5 2020
medline: 2 2 2021
Statut: ppublish

Résumé

In this comparative study, we examine the safety of the sheeppox (SPP) and goatpox (GTP) vaccines and the protective response of these vaccines in cattle against a virulent lumpy skin disease (LSD) field strain. The vaccine safety was tested in rabbits, mice and cattle using ten times recommended dose. In the safety trial, none of the vaccinated animals showed any deviation from physiological norms or fever, inappetence or local/ generalized skin reactions. In the challenge trial, both SPP and GTP vaccine groups developed virus-neutralizing antibodies with an average titre of 2.1 log

Identifiants

pubmed: 32456811
pii: S0378-1135(20)30041-9
doi: 10.1016/j.vetmic.2020.108695
pii:
doi:

Substances chimiques

Viral Vaccines 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108695

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.

Auteurs

K Zhugunissov (K)

Research Institute for Biological Safety Problems, Gvardeiskiy, Kazakhstan. Electronic address: kuandyk_83@mail.ru.

Ye Bulatov (Y)

Research Institute for Biological Safety Problems, Gvardeiskiy, Kazakhstan.

M Orynbayev (M)

Research Institute for Biological Safety Problems, Gvardeiskiy, Kazakhstan.

L Kutumbetov (L)

Research Institute for Biological Safety Problems, Gvardeiskiy, Kazakhstan.

Ye Abduraimov (Y)

Research Institute for Biological Safety Problems, Gvardeiskiy, Kazakhstan.

Ye Shayakhmetov (Y)

Research Institute for Biological Safety Problems, Gvardeiskiy, Kazakhstan.

D Taranov (D)

Research Institute for Biological Safety Problems, Gvardeiskiy, Kazakhstan.

Zh Amanova (Z)

Research Institute for Biological Safety Problems, Gvardeiskiy, Kazakhstan.

M Mambetaliyev (M)

Research Institute for Biological Safety Problems, Gvardeiskiy, Kazakhstan.

Zh Absatova (Z)

Research Institute for Biological Safety Problems, Gvardeiskiy, Kazakhstan.

M Azanbekova (M)

Research Institute for Biological Safety Problems, Gvardeiskiy, Kazakhstan.

B Khairullin (B)

Research Institute for Biological Safety Problems, Gvardeiskiy, Kazakhstan.

K Zakarya (K)

Research Institute for Biological Safety Problems, Gvardeiskiy, Kazakhstan.

E Tuppurainen (E)

Institut für Internationale Tiergesundheit / One Health, Friedrich-Loeffler Institut, Südufer 10, 17493 Greifswald, Insel Riems, Germany. Electronic address: eeva.tuppurainen@fli.de.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH